In human glioblastoma, C/EBPβ and Stat3 have been reported as master transcriptional regulators of mesenchymal transformation, a characteristic of tumor aggressiveness, and prognostic factors for poor clinical outcome [21]. This evidence concerns the gene CEBPB and glioblastoma.